Literature DB >> 2997472

Utilization of internal AUG codons for initiation of protein synthesis directed by mRNAs from normal and mutant genes encoding herpes simplex virus-specified thymidine kinase.

L Haarr, H S Marsden, C M Preston, J R Smiley, W C Summers, W P Summers.   

Abstract

Previous studies (H.S. Marsden, L. Haarr, and C.M. Preston, J. Virol. 46:434-445, 1983) have shown that at least three polypeptides, with molecular weights of 43,000, 39,000, and 38,000, are encoded by the herpes simplex virus type 1 (HSV-1) thymidine kinase (TK) gene. It has been suggested that the 39,000- and 38,000-molecular-weight polypeptides arise from preinitiation complexes bypassing the first and second AUG codons before commencement of translation since, according to previous work (M. Kozak, Nucleic Acids Res. 9:5233-5252, 1981), these codons are not of the most efficient structure for initiation. This possibility was investigated by using specific herpes simplex virus mutants with alterations in the TK gene. Mutant TK4 has an amber mutation between the first and second AUG codons, whereas mutant delta 1 has a deletion which removes the first AUG codon but leaves other AUG codons, as well as transcriptional promoter sequences, intact. Both mutants synthesized only the 39,000- and 38,000-molecular-weight polypeptides, and the amounts produced were normal in TK4-infected cells but increased in delta 1-infected cells. Furthermore, the levels of TK produced after infection with the mutant viruses correlated with the amounts of the 39,000- and 38,000-molecular-weight polypeptides synthesized. The 43,000-, 39,000-, and 38,000-molecular-weight polypeptides were shown to be related by their positive reaction with anti-TK serum in both immunoprecipitation and immunoblotting experiments. The production of the 39,000- and 38,000-molecular-weight polypeptides through bypassing of the first AUG codon was examined by hybrid arrest experiments with a DNA fragment complementary to only 50 bases at the 5' terminus of TK mRNA. This fragment arrested the synthesis of the 30,000- and 38,000-molecular-weight polypeptides when annealed to mRNA from wild-type HSV-1- or TK4-infected cells, showing that those polypeptides arise from an mRNA initiated upstream from the first AUG codon. mRNA from cells infected with mutant delta 1, which lacks DNA sequences upstream from the first AUG, was not affected by the 50-base-pair fragment. The data therefore confirm that three polypeptides encoded by the HSV-1 TK gene arise by differential use of in-phase AUG codons for the initiation of protein synthesis. This mechanism for the production of related but distinct polypeptides has not previously been demonstrated in a eucaryotic system, and the implications for the regulation of TK enzyme activities are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2997472      PMCID: PMC252607     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Possible peptide chain termination mutants in thymide kinase gene of a mammalian virus, herpes simplex virus.

Authors:  W P Summers; M Wagner; W C Summers
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

2.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

3.  Late messenger RNA production by viable simian virus 40 mutants with deletions in the leader region.

Authors:  M Piatak; K N Subramanian; P Roy; S M Weissman
Journal:  J Mol Biol       Date:  1981-12-15       Impact factor: 5.469

4.  Analysis of the TK enzyme complex induced by HSV types 1 and 2 by means of isoelectric focusing and polyacrylamide gel electrophoresis.

Authors:  J Labenz; D Friedrich; D Falke
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

5.  Selection of initiation sites by eucaryotic ribosomes: effect of inserting AUG triplets upstream from the coding sequence for preproinsulin.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1984-05-11       Impact factor: 16.971

6.  Functional suppression in mammalian cells of nonsense mutations in the herpes simplex virus thymidine kinase gene by suppressor tRNA genes.

Authors:  W P Summers; W C Summers; F A Laski; U L RajBhandary; P A Sharp
Journal:  J Virol       Date:  1983-08       Impact factor: 5.103

7.  Processing of herpes simplex virus proteins and evidence that translation of thymidine kinase mRNA is initiated at three separate AUG codons.

Authors:  H S Marsden; L Haarr; C M Preston
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

8.  The 2.2 kb E1b mRNA of human Ad12 and Ad5 codes for two tumor antigens starting at different AUG triplets.

Authors:  J L Bos; L J Polder; R Bernards; P I Schrier; P J van den Elsen; A J van der Eb; H van Ormondt
Journal:  Cell       Date:  1981-11       Impact factor: 41.582

9.  Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1981-10-24       Impact factor: 16.971

10.  The complete sequence and coding content of snowshoe hare bunyavirus small (S) viral RNA species.

Authors:  D H Bishop; K G Gould; H Akashi; C M Clerx-van Haaster
Journal:  Nucleic Acids Res       Date:  1982-06-25       Impact factor: 16.971

View more
  21 in total

1.  Evidence that neomycin inhibits binding of herpes simplex virus type 1 to the cellular receptor.

Authors:  N Langeland; H Holmsen; J R Lillehaug; L Haarr
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

2.  Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene.

Authors:  S D Lupton; L L Brunton; V A Kalberg; R W Overell
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

3.  Initiation of herpes simplex virus thymidine kinase polypeptides.

Authors:  A R Ellison; J O Bishop
Journal:  Nucleic Acids Res       Date:  1996-06-01       Impact factor: 16.971

4.  Identification of the gene encoding the 65-kilodalton DNA-binding protein of herpes simplex virus type 1.

Authors:  D S Parris; A Cross; L Haarr; A Orr; M C Frame; M Murphy; D J McGeoch; H S Marsden
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

5.  The 65,000-Mr DNA-binding and virion trans-inducing proteins of herpes simplex virus type 1.

Authors:  H S Marsden; M E Campbell; L Haarr; M C Frame; D S Parris; M Murphy; R G Hope; M T Muller; C M Preston
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

6.  Rapid phenotypic characterization method for herpes simplex virus and Varicella-Zoster virus thymidine kinases to screen for acyclovir-resistant viral infection.

Authors:  T Suzutani; M Saijo; M Nagamine; M Ogasawara; M Azuma
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

7.  Effect of telomere proximity on telomere position effect, chromosome healing, and sensitivity to DNA double-strand breaks in a human tumor cell line.

Authors:  Avanti Kulkarni; Oliver Zschenker; Gloria Reynolds; Douglas Miller; John P Murnane
Journal:  Mol Cell Biol       Date:  2009-11-23       Impact factor: 4.272

8.  Site-directed mutagenesis in the active site of the herpes simplex virus type 1 thymidine kinase gene.

Authors:  J Fetzer; G Folkers; I Müller; G M Keil
Journal:  Virus Genes       Date:  1993-06       Impact factor: 2.332

9.  Identification of a novel latency-specific splice donor signal within the herpes simplex virus type 1 2.0-kilobase latency-associated transcript (LAT): translation inhibition of LAT open reading frames by the intron within the 2.0-kilobase LAT.

Authors:  J G Spivack; G M Woods; N W Fraser
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

10.  Regulated expression of a transfected human cardiac actin gene during differentiation of multipotential murine embryonal carcinoma cells.

Authors:  M A Rudnicki; M Ruben; M W McBurney
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.